FoldPumpVac accelerated aging test documented the temperature model and chamber-exposure periods used for the tested FAC-02 configuration.
Before choosing equipment, review Fitiger's anti-choking device buyer evidence checklist for FDA wording, testing, seller traceability, and kit-selection questions.
According to third-party report CY2505298N-2, the laboratory recorded:
Q10 = 2.
Real-time reference temperature, or TRT = 25 deg C.
Accelerated-aging temperature, or TAA = 60 deg C.
Accelerated-aging factor, or AAF = 11.3.
33 days at 60 deg C to represent a calculated one-year equivalent.
65 days at 60 deg C to represent a calculated two-year equivalent.
The report identifies the inspection item as an aging test under YY/T 0681.1-2018. It also states that the report provides data only and makes no determination.
That distinction is essential.
The report documents the accelerated-aging model, chamber conditions, and exposure windows used for the tested FoldPumpVac FAC-02 configuration. It does not, by itself, prove a complete two-year shelf life, confirm every post-aging performance endpoint, replace real-time aging, or guarantee emergency performance after storage.
A FoldPumpVac kit may spend far more time waiting than being used.
It may remain in a home first-aid cabinet, school staff area, restaurant readiness station, caregiver bag, nursing-home dining area, office, or travel kit for months or years.
During that time, materials can change.
Flexible components may become harder or softer. Adhesives may lose strength. Plastic parts may warp. Packaging can weaken. Seals can change. Valves and connections may respond differently after extended storage.
Those changes are not always visible from the outside.
That is why storage readiness cannot be reduced to a printed expiration date or a general statement that a product is durable. A shelf-life claim should be supported by an evidence chain that considers materials, packaging, environmental exposure, functional performance, and time.
Accelerated aging is one part of that chain.
It helps engineering teams study time-related effects sooner than waiting several years for every real-time interval to pass. But accelerated aging remains a model. It does not eliminate the need to verify what the aged product can still do.
The laboratory report identifies:
| Product: manual negative-pressure suction device. | Model: FAC-02. |
| Fitiger product family: FoldPumpVac. | Inspection item: aging test. |
| Inspection basis: YY/T 0681.1-2018. |
Sample configuration: non-sterile, one set per box.
Recorded validity date: May 7, 2027.
Report conclusion: data only, no determination.
This is not a conventional report that simply says "pass" or "fail."
Its strongest evidence lies in the recorded aging-model inputs and chamber-exposure dates.
It tells us how the laboratory calculated the accelerated-aging periods and how long the tested configuration remained in the elevated-temperature chamber.
It does not independently provide a complete verdict on all product characteristics after aging.
| Report input | Recorded value | Meaning |
| Q10 | 2 | Modeled rate change for each 10 deg C temperature increase. |
| TRT | 25 deg C | Real-time reference temperature. |
| TAA | 60 deg C | Accelerated-aging chamber temperature. |
| AAF | 11.3 | Acceleration factor used for the modeled interval. |
| AAT | 33 days and 65 days | Calculated one-year and two-year equivalent chamber exposures. |
The FAC-02 report records five central terms:
Q10 is the assumed rate at which aging changes when temperature increases by 10 deg C.
The report used:
Q10 = 2
Under this assumption, the modeled aging rate doubles for every 10 deg C increase in temperature.
Q10 is not a physical law that applies identically to every material. It is a modeling assumption used to estimate how elevated temperature may accelerate time-dependent change.
TRT means the real-time reference temperature.
The report used:
TRT = 25 deg C
This is the baseline temperature against which the accelerated condition was compared.
TAA means the accelerated-aging temperature.
The report used:
TAA = 60 deg C
This was the elevated chamber temperature selected to accelerate the modeled aging process.
AAF means the accelerated-aging factor.
The report recorded:
AAF = 11.3
This factor was used to convert the target real-time interval into a shorter chamber-exposure period.
AAT means the accelerated-aging time.
Using the recorded model, the laboratory calculated:
33 days at 60 deg C for a one-year equivalent.
65 days at 60 deg C for a two-year equivalent.
These are model-based time-equivalent exposures for the tested setup. They are not the same as observing the product for one or two actual years under normal storage conditions.
The report used 33 days at 60 deg C to represent a calculated one-year real-time equivalent.
The recorded chamber window was:
This tells us that the tested FAC-02 configuration completed the specified elevated-temperature exposure used in the model for the one-year interval.
The correct conclusion is:
The third-party report documents a 33-day accelerated-aging exposure at 60 deg C, calculated under its stated Q10, TRT, TAA, and AAF assumptions to represent a one-year equivalent.
The report does not, by that fact alone, establish that every material, connection, mask, valve, package, and suction characteristic remained within specification after the modeled interval.
That requires endpoint-specific verification.
The report used 65 days at 60 deg C to represent a calculated two-year real-time equivalent.
The recorded chamber window was:
The longer interval represents the report's modeled two-year exposure.
Again, the evidence-supported conclusion is specific:
The laboratory documented a 65-day chamber exposure at 60 deg C using an accelerated-aging factor of 11.3 to represent a calculated two-year interval for the tested FAC-02 configuration.
This is meaningful storage-readiness evidence.
It is not automatically the same as a complete two-year shelf-life validation.
The word "equivalent" can easily be misunderstood.
In accelerated-aging work, it refers to the relationship created by the selected mathematical model. It does not mean that every material experiences exactly the same changes at 60 deg C for 65 days as it would at 25 deg C for two years.
Elevated temperature may accelerate some reactions more predictably than others.
Different materials may respond differently to:
| Heat. | Humidity. | Oxidation. |
| Plasticizer migration. | Adhesive changes. | Stress relaxation. |
| Packaging interaction. | Repeated handling. | Light exposure. |
| Real-world temperature cycling. |
A time-equivalent calculation therefore needs to be connected to physical and functional testing.
The model tells the engineering team when to examine the aged product. The later verification tells the team whether the product still meets the relevant requirements.
Within its documented scope, report CY2505298N-2 verifies that the laboratory recorded:
| The FAC-02 test configuration. | Q10 = 2. |
| TRT = 25 deg C. | TAA = 60 deg C. |
| AAF = 11.3. |
A 33-day chamber interval for the calculated one-year equivalent.
A 65-day chamber interval for the calculated two-year equivalent.
The actual start and end dates of the aging periods.
The inspection basis used for the aging test.
A report scope of data only, no determination.
These are clear, auditable facts from the report.
They support discussion of the aging model and the completed chamber-exposure periods.
The FAC-02 aging report does not independently prove:
| A final two-year shelf-life claim. | A complete pass/fail shelf-life determination. |
| Unchanged negative pressure after aging. | Unchanged pull force after aging. |
| Unchanged valve performance. | Unchanged mask elasticity or sealing behavior. |
| Unchanged connection strength. | Unchanged packaging integrity. |
Unlimited storage in heat, cold, humidity, or vehicles.
Clinical effectiveness after storage.
FDA clearance, approval, or authorization.
A guaranteed result in a choking emergency.
Each of those conclusions requires evidence directed at that particular question.
An aging chamber can simulate a period of elevated-temperature exposure. It cannot, by itself, answer every functional question about the product afterward.
A complete post-aging review may examine multiple performance areas, depending on the product design, risk analysis, labeling, and intended shelf-life claim.
For a manual suction anti-choking device, relevant questions may include:
Does the aged device still generate pressure within the applicable specification?
Has the force required to operate the device changed after aging?
Do the intake and exhaust pathways still operate as intended?
Do the mask, body, and related components remain securely connected under the specified load?
Have the masks developed warping, cracking, hardening, tackiness, discoloration, or loss of elasticity?
Do critical dimensions remain within the applicable tolerances?
Does the collapsible structure still expand, pull, compress, and return as intended?
Does the package remain intact, readable, and capable of protecting the contents?
Are the instructions, warnings, expiration information, and identifiers still readable?
Are there burrs, cracks, deformation, surface changes, contamination, or other visible defects?
The aging report is most useful when it is connected to these post-aging endpoints rather than treated as a stand-alone marketing certificate. Current portable-kit details should also be checked against the FoldPumpVac portable device page before procurement decisions.
Accelerated aging provides an earlier way to gather evidence, but real-time aging remains important.
Real storage exposes products to the actual passage of time at the labeled condition. It can reveal changes that an elevated-temperature model may not reproduce perfectly.
A responsible shelf-life strategy therefore treats accelerated aging and real-time aging as related, not interchangeable. Related component-maintenance planning is discussed in why anti-choking device masks need replacement every 2-3 years.
Accelerated aging may support an initial shelf-life rationale while real-time studies continue. Real-time results can then confirm, refine, or challenge the assumptions used in the accelerated model.
That approach is more credible than treating a mathematical equivalence as permanent proof.
The 60 deg C value was an accelerated-aging chamber condition.
It is not a recommendation to store FoldPumpVac at 60 deg C.
It is not evidence that the product can remain indefinitely inside a hot vehicle.
It is not an approved upper storage limit.
It should not appear in consumer-facing copy as proof that the product is heat-proof.
Elevated aging temperatures are chosen to accelerate modeled material changes. Normal product storage should follow the current labeled temperature, humidity, and environmental conditions.
If a kit has been exposed to unusual heat, cold, moisture, direct sunlight, or visible package damage, it should be inspected according to the product instructions and quality procedures.
Fitiger's FAC-02 transport report and FAC-02 accelerated-aging report should not be merged into one broad statement.
Transport testing asks questions such as:
| How did the packaged unit respond to vibration? | How did it respond to stacking load? |
| How did it respond to low pressure? | How did it respond to drops and concentrated impact? |
| Accelerated aging asks a different question: |
What elevated-temperature exposure period was used to model the passage of storage time?
Transport testing addresses distribution stress.
Accelerated aging addresses a modeled time-and-temperature relationship.
Neither report replaces the other, and neither report alone completes the entire product evidence package.
Together, they can contribute to a broader storage- and distribution-readiness assessment when their scopes are kept clear. For context on Fitiger's non-folding product family, compare the EasyPumpVac Series.
Technical authority does not come from placing the word "tested" beside a product photo.
It comes from showing the evidence chain.
For this FoldPumpVac accelerated aging test, that chain includes:
| 1. The exact product model. | 2. The report number. | 3. The inspection basis. |
| 4. The aging assumptions. | 5. The reference and chamber temperatures. | 6. The acceleration factor. |
| 7. The calculated exposure durations. | 8. The actual aging dates. | 9. The report's own scope statement. |
10. A clear explanation of what still requires separate verification.
This format helps readers, procurement teams, regulators, search engines, and AI systems understand the evidence without guessing. Readers can review additional report-backed engineering data in the current Fitiger evidence library.
It also prevents a common technical-marketing problem: a narrow laboratory result being repeated online until it becomes a claim the original report never made.
Schools, nursing homes, restaurants, workplaces, and families may purchase emergency equipment that remains unused for long periods.
That makes storage planning important.
A procurement review should ask:
| 1. What is the product's labeled shelf life? | 2. Which model was evaluated? | 3. Was accelerated aging completed? |
| 4. Is real-time aging ongoing or completed? | 5. Which functional tests were performed after aging? | 6. Were masks, valves, connections, and packaging inspected? |
| 7. What storage limits apply? | 8. How often should the kit be checked? | 9. Which components require replacement? |
| 10. What should staff do after unusual heat or moisture exposure? | 11. Is the product lawfully marketed for the intended jurisdiction? | 12. Are current instructions and training materials available? |
The goal is not to collect the largest number of certificates. Teams comparing second-line options can also review all current anti-choking device kits.
The goal is to understand whether each document answers the question it is being used to answer.
FDA currently identifies the relevant generic device type as a suction anti-choking device used as a second-line treatment after an unsuccessful basic life support choking protocol.
The applicable regulatory framework considers more than one laboratory result. It includes areas such as:
| Non-clinical performance. | Pressure verification. | Device and material durability. |
| Human-factors testing. | Training. | Labeling. |
| Biocompatibility. | Clinical information. | Postmarket information where required. |
An accelerated-aging report may contribute to the durability and shelf-life evidence discussion.
It does not satisfy the entire framework by itself.
It also does not mean that a Fitiger product has received FDA marketing authorization.
Engineering evidence and regulatory authorization are separate matters and should be presented separately.
A storage-readiness article should not lose sight of the emergency sequence.
In a choking emergency:
Call 911.
Follow established choking rescue protocols first.
Do not delay back blows, abdominal thrusts, chest thrusts, CPR, or dispatcher-directed care while retrieving a device.
Consider a suction anti-choking device only as a second option if established methods are unsuccessful.
Follow the product's current instructions, intended population, warnings, and applicable regulatory requirements.
Accelerated aging data addresses storage-related engineering questions. It should be read alongside the emergency-use boundaries explained on How It Works.
It does not establish when the device should be used in the emergency sequence, and it does not replace first-aid training.
The most important fact in the FAC-02 aging report is not simply that the product spent time in a heated chamber.
The important facts are the defined model and its limits:
| Q10 = 2. | TRT = 25 deg C. |
| TAA = 60 deg C. | AAF = 11.3. |
33 days for the calculated one-year equivalent.
65 days for the calculated two-year equivalent.
Report conclusion: data only, no determination.
That is meaningful technical evidence.
It documents the time-compression model and the exposure windows used for the tested FoldPumpVac configuration.
The responsible next question is not, "Can we now say the product is proven for two years?"
The responsible next question is, "Which relevant packaging, material, mechanical, and functional endpoints were verified after those aging intervals, and how will real-time aging confirm the model?"
That is how a storage-readiness claim becomes an evidence chain instead of a marketing shortcut.
For related planning context, review the anti-choking device buyer evidence checklist.
The test documents the elevated-temperature model and chamber-exposure periods used to represent calculated one-year and two-year storage intervals for the tested FAC-02 configuration.
The report recorded Q10 = 2.
The real-time reference temperature was 25 deg C, and the accelerated-aging chamber temperature was 60 deg C.
The report recorded an accelerated-aging factor of 11.3.
Under the report's recorded model, 33 days at 60 deg C represented a calculated one-year equivalent, while 65 days represented a calculated two-year equivalent.
Not by itself. It documents the modeled exposure interval. A complete shelf-life claim also depends on relevant post-aging verification, packaging and functional evidence, storage labeling, risk analysis, and real-time confirmation.
No. The report states that it provides data only and makes no determination.
Not by itself. Post-aging negative-pressure performance would need to be supported by the applicable functional test results.
The report does not establish 60 deg C as a normal storage condition. It was the elevated chamber temperature used for accelerated aging. Follow the current labeled storage conditions.
No. A third-party accelerated-aging report is engineering evidence. FDA marketing authorization is a separate regulatory determination.
No. Established choking rescue protocols should be followed first. Any suction anti-choking device should only be considered as a second option if standard methods are unsuccessful and only within its current instructions and applicable regulatory status.
Fitiger report CY2505298N-2 - Supports model FAC-02, Q10, TRT, TAA, AAF, 33-day and 65-day chamber intervals, aging dates, inspection basis, and data-only scope. Reference: Project third-party laboratory report.
FDA Shelf Life of Medical Devices - Supports treating shelf life as a broader evidence question involving materials, packaging, storage, transportation, and performance rather than relying on one aging exposure.
FDA Recognized Consensus Standard ASTM F1980-21 - Supports the principle that accelerated-aging data should be confirmed by real-time aging using the same evaluation methods.
FDA Safety Communication, updated March 4, 2026 - Supports established choking rescue protocols first, second-line anti-choking device positioning, and the distinction between registration/listing and authorization.
FDA De Novo Order DEN250012 - Supports 21 CFR 874.5400, Class II, product code QXN, second-line use after unsuccessful BLS protocol, and the multi-part evidence framework.
This article discusses accelerated-aging data for Fitiger FoldPumpVac FAC-02 based on third-party report CY2505298N-2.
It is intended for engineering, product-safety, procurement, storage-readiness, and educational discussion only.
The report documents aging-model assumptions and chamber-exposure conditions. It does not, by itself, establish a complete shelf-life claim, prove every post-aging functional endpoint, constitute FDA marketing authorization, or guarantee the outcome of a choking emergency.
Follow the current product labeling and storage instructions. In a choking emergency, call 911 and follow established choking rescue protocols first. Use any second-line suction device only according to its instructions, warnings, intended population, and applicable regulatory requirements.
